Tumor exosomes expressing Fas ligand mediate CD8+ T-cell apoptosis

被引:375
作者
Abusamra, AJ
Zhong, ZH
Zheng, XF
Li, M
Ichim, TE
Chin, JL
Min, WP
机构
[1] London Hlth Sci Ctr, London, ON, Canada
[2] Univ Western Ontario, Dept Surg Microelect & Immunol & Pathol, London, ON N6A 5A5, Canada
[3] Cent S Univ, Hunan, Peoples R China
关键词
cancer immune evasion; exosome; FasL; apoptosis; CD8(+) T cells;
D O I
10.1016/j.bcmd.2005.07.001
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Tumor-derived immune suppression is considered to be a major mechanism of tumor evasion from the immune system destruction, however, little is known regarding the induction of T-cell functional suppression by tumor-derived exosomes. Herein, we investigate tumor-derived exosomes involved in normal immunological communications as means of inhibiting an antitumor T-cell response. Exosomes derived from LNCaP, a human prostate cancer cell line, were visualized by FACS and identified based on size (80-200 nm) in comparison to marker beads. Exosomes from tumor cell line inhibited T-cell proliferation. Dose-dependent apoptosis of T cells was induced by co-culture with tumor exosomes. Addition of anti-FasL antibody blocked the apoptosis induction by tumor exosomes. This study suggests that induction of T-cell apoptosis by tumor-derived exosomes appears to be a novel mechanism of tumor immune evasion. (c) 2005 Elsevier Inc. All rights reserved.
引用
收藏
页码:169 / 173
页数:5
相关论文
共 24 条
[1]   Induction of lymphocyte apoptosis by tumor cell secretion of FasL-bearing microvesicles [J].
Andreola, G ;
Rivoltini, L ;
Castelli, C ;
Huber, V ;
Perego, P ;
Deho, P ;
Squarcina, P ;
Accornero, P ;
Lozupone, F ;
Lugini, L ;
Stringaro, A ;
Molinari, A ;
Arancia, G ;
Gentile, M ;
Parmiani, G ;
Fais, S .
JOURNAL OF EXPERIMENTAL MEDICINE, 2002, 195 (10) :1303-1316
[2]   CD8+ T cell tolerance and cancer immunotherapy [J].
de Visser, KE ;
Schumacher, TNM ;
Kruisbeek, AM .
JOURNAL OF IMMUNOTHERAPY, 2003, 26 (01) :1-11
[3]   SPECIFIC BLOCKING FACTORS - ARE THEY IMPORTANT [J].
HELLSTROM, KE ;
HELLSTROM, I ;
NEPOM, JT .
BIOCHIMICA ET BIOPHYSICA ACTA, 1977, 473 (02) :121-148
[4]  
Karlsson M, 2001, EUR J IMMUNOL, V31, P2892, DOI 10.1002/1521-4141(2001010)31:10<2892::AID-IMMU2892>3.0.CO
[5]  
2-I
[6]   CD4+ T cell-mediated cytotoxicity toward thyrocytes:: The importance of Fas/Fas ligand interaction inducing apoptosis of thyrocytes and the inhibitory effect of thyroid-stimulating hormone [J].
Kawakami, A ;
Matsuoka, N ;
Tsuboi, M ;
Koji, T ;
Urayama, S ;
Sera, N ;
Hida, A ;
Usa, T ;
Kimura, H ;
Yokoyama, N ;
Nakashima, T ;
Ishikawa, N ;
Ito, K ;
Kawabe, Y ;
Eguchi, K .
LABORATORY INVESTIGATION, 2000, 80 (04) :471-484
[7]   Tumor-induced immune dysfunction [J].
Kiessling, R ;
Wasserman, K ;
Horiguchi, S ;
Kono, K ;
Sjöberg, J ;
Pisa, P ;
Petersson, M .
CANCER IMMUNOLOGY IMMUNOTHERAPY, 1999, 48 (07) :353-362
[8]   Production and characterization of clinical grade exosomes derived from dendritic cells [J].
Lamparski, HG ;
Metha-Damani, A ;
Yao, JY ;
Patel, S ;
Hsu, DH ;
Ruegg, C ;
Le Pecq, JB .
JOURNAL OF IMMUNOLOGICAL METHODS, 2002, 270 (02) :211-226
[9]  
Maccalli C, 1999, J IMMUNOL, V163, P6912
[10]  
Martínez-Lorenzo MJ, 1999, J IMMUNOL, V163, P1274